The Immunomodulatory Effects of Oral Nanocurcumin in Multiple Sclerosis Patients

NCT03150966 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Nanocurcumin
DRUG: Placebo

Sponsor

Tabriz University of Medical Sciences